Foresite Capital Management V, LLC

CIK: 0001792206

Transaction Breakdown

Open Market Buys (P)1 (12.5%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)7 (87.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LTGO

Latigo Biotherapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (8 total)

LTGO
Latigo Biotherapeutics, Inc.
Aug 10, 2026
Conversion(C)
Indirect
3.1M shares-
LTGO
Latigo Biotherapeutics, Inc.
Aug 10, 2026
Conversion(C)
Indirect
445.3K shares-
LTGO
Latigo Biotherapeutics, Inc.
Aug 10, 2026
Conversion(C)
Indirect
1.1M shares-
LTGO
Latigo Biotherapeutics, Inc.
Aug 10, 2026
Conversion(C)
Indirect
742.2K shares-
LTGO
Latigo Biotherapeutics, Inc.
Aug 10, 2026
Purchase(P)
Indirect
140K shares at avg. $18.00$2.5M
LTGO
Latigo Biotherapeutics, Inc.
Aug 10, 2026
Conversion(C)
Indirect
195.8K shares-
LTGO
Latigo Biotherapeutics, Inc.
Aug 10, 2026
Conversion(C)
Indirect
3.1M shares-
LTGO
Latigo Biotherapeutics, Inc.
Aug 10, 2026
Conversion(C)
Indirect
296.9K shares-

		Type	Shares	Price		Ownership
Aug 10, 2026	LTGO Latigo Biotherapeutics, Inc.	Conversion(C)	3,117,664	-	$0	Indirect
Aug 10, 2026	LTGO Latigo Biotherapeutics, Inc.	Conversion(C)	445,320	-	$0	Indirect
Aug 10, 2026	LTGO Latigo Biotherapeutics, Inc.	Conversion(C)	1,125,823	-	$0	Indirect
Aug 10, 2026	LTGO Latigo Biotherapeutics, Inc.	Conversion(C)	742,201	-	$0	Indirect
Aug 10, 2026	LTGO Latigo Biotherapeutics, Inc.	Purchase(P)	140,000	$18.00	$2,520,000	Indirect
Aug 10, 2026	LTGO Latigo Biotherapeutics, Inc.	Conversion(C)	195,776	-	$0	Indirect
Aug 10, 2026	LTGO Latigo Biotherapeutics, Inc.	Conversion(C)	3,117,664	-	$0	Indirect
Aug 10, 2026	LTGO Latigo Biotherapeutics, Inc.	Conversion(C)	296,880	-	$0	Indirect

1-8 of 8 transactions

About Foresite Capital Management V, LLC

Foresite Capital Management V, LLC (SEC CIK 0001792206) files insider reports with the SEC as 10% Owner of Latigo Biotherapeutics, Inc. (LTGO).

Signal8 holds 2 ownership filings by Foresite Capital Management V, LLC (1 Form 3, 1 Form 4), filed between Aug 6, 2026 and Aug 10, 2026. Those filings report 8 transactions, the latest on Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Foresite Capital Management V, LLC's filings is in WEST HOLLYWOOD, CA.

Recent filings by Foresite Capital Management V, LLC

Aug 10, 2026: Conversions of LTGO shares (4 lines, Form 4, code C).
Aug 10, 2026: Open-market purchase of LTGO shares (Form 4, code P).
Aug 10, 2026: Conversions of LTGO shares (3 lines, Form 4, code C).

Other insiders filing for Latigo Biotherapeutics, Inc. (LTGO)

5AM Ventures VI, L.P., 10% Owner
Sanofi, 10% Owner
Westlake BioPartners Fund I, L.P., 10% Owner
SMITH TODD N, Director
Tananbaum James B., Director
SEIDENBERG BETH C, Director

How to read Form 4 transaction codes